AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication in peer-reviewed journal Nature Medicine of 12-month ...
Please provide your email address to receive an email when new articles are posted on . About 6.7 million Americans have heart failure and it accounts for 45% of heart-related deaths. One in four ...
Heart attack and heart failure are two distinct but often confused cardiovascular conditions. A heart attack occurs suddenly when blood flow to part of the heart muscle is blocked, causing tissue ...
Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...
“ENBUMYST was developed with the goal of giving providers a new, self-administered outpatient option,” said Brian Kolski M.D., Chief Medical Officer of Corstasis Therapeutics. “Our collaboration with ...
Cupid’s got nothing to do with this kind of heartache. A silent epidemic is sweeping the nation, with the number of Americans living with heart failure expected to soar from 6.7 million in 2024 to a ...
They can look like a million dollars one day and be lying dead in the dirt the next week. That’s the reality of Bovine Congestive Heart Failure in feedlot cattle, and with cattle prices at all-time ...
Edema and fluid overload remain the leading causes of hospitalization and readmission for patients with CHF, cirrhosis, and chronic kidney disease. An estimated 6.7 million Americans live with heart ...
Did you know that our beloved pets can suffer from heart problems just like we do? Heart disease in pets could eventually lead to congestive heart failure. This is a condition where the heart has ...
Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...
The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback